| CTRI Number |
CTRI/2020/06/026226 [Registered on: 29/06/2020] Trial Registered Prospectively |
| Last Modified On: |
23/06/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Ayurveda Other (Specify) [Lepana] |
| Study Design |
Other |
|
Public Title of Study
|
Ayurvedic preparation and medicine use in the management of haemorrhoids |
|
Scientific Title of Study
|
A Clinical Study to Evaluate the Efficacy of Arshakalp Vati and Snuk-Ksheeradi Lepa in Guda Arsha w.s.r. to Haemorrhoids. |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr MP Singh |
| Designation |
Professor and Head |
| Affiliation |
Patanjali Bhartiya Ayurvigyan Evum Anusandhan sansthan |
| Address |
P.G Department of shalya tantra, Patanjali bhartiya ayurvigyan evum anusandhan sansthan, Haridwar
Hardwar UTTARANCHAL 249405 India |
| Phone |
|
| Fax |
|
| Email |
manojpratap05@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr MP Singh |
| Designation |
Professor and Head |
| Affiliation |
Patanjali Bhartiya Ayurvigyan Evum Anusandhan sansthan |
| Address |
P.G Department of shalya tantra, Patanjali bhartiya ayurvigyan evum anusandhan sansthan, Haridwar
Hardwar UTTARANCHAL 249405 India |
| Phone |
|
| Fax |
|
| Email |
manojpratap05@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Pooja Sinha |
| Designation |
M.S Scholar |
| Affiliation |
Patanjali Bhartiya Ayurvigyan Evum Anusandhan sansthan |
| Address |
P.G Department of shalya tantra, Patanjali bhartiya ayurvigyan evum anusandhan sansthan, Haridwar Patanjali girls hostel, post office, Patanjali Yogpeeth Phase 1, Hardwar UTTARANCHAL 249405 India |
| Phone |
8171411461 |
| Fax |
|
| Email |
poojasinha2912@gmail.com |
|
|
Source of Monetary or Material Support
|
| Patanjali Bhartiya Ayurvigyan Evum Anusandhan Sansthan |
|
|
Primary Sponsor
|
| Name |
Pooja Sinha |
| Address |
Patanjali girls hostel, post office, Patanjali Yogpeeth Phase 1, Haridwar |
| Type of Sponsor |
Other [] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DrManoj Pratap Singh |
PATANJALI BHARTIYA AYURVIGYAN EVUM ANUSANDHAN SANSTHAN |
PATANJALI YOGPEETH PHASE-1, MAHARISHI DAYANAND GRAM,DELHI-HARIDWAR HIGHWAY, NEAR BAHADARABAD, HARIDWAR Hardwar UTTARANCHAL |
8171411461
manojpratap05@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUTIONAL ETHICAL COMITEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K928||Other specified diseases of the digestive system, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Arshakalp Vati |
A vati is prepared with daruharidra,haritaki,mahanimb,nimb,reetha,karpura, raktaniryasa,makoya, ghritakumari,nagadaun. The dose will be 2 tablets of 500mg each BD Before meal with lukewarm water. Duration of study- 3 months |
| Comparator Agent |
NOT APPLICABLE |
Not APPLICABLE |
| Intervention |
Snuk-ksheeradi lepa |
Lepa prepared by Snuhi ksheer and Haridra, Snuhi ksheer will be mixed with haridra powder and pralepa will be made. The lepa will apply on the affected part of the body Bahya-abhyantara.
• Two times a day after hot sitz bath.
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Patients age ranging from 18 to 60 years.
The patients having complaints of I and II-degree hemorrhoids will be taken for the study after
screening.
External pile mass of small in size.
Patients willing to undergo trial and ready to give informed and written consent. |
|
| ExclusionCriteria |
|
|
Method of Generating Random Sequence
|
Random Number Table |
|
Method of Concealment
|
An Open list of random numbers |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Patients of either sex 18 to 60 years old having hemorrhoids will be selected |
3 months |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
To study the etipathogenesis of hemorrhoids on the basis of ayurvedic parameters.
To study the effect of ayurvedic formulation and lepana karma in the management of hemorrhoids.
To provide reliable cost effective Ayurvedic treatment for hemorrhoids |
90 days |
|
|
Target Sample Size
|
Total Sample Size="30" Sample Size from India="30"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 1/ Phase 2 |
|
Date of First Enrollment (India)
|
02/07/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
None yet |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
Patients of either sex and 18 to 60 years 1st or 2nd degree hemorrhoids will be selected. The criteria of assessment will be done on the basis of subjective and objective parameters. Subjective parameters include symptoms like pain in , constipation, bleeding per rectum, prolapse pile mass per rectum. Objective assessment will be done site-internal/external/-external, Surface- even/uneven/smooth, position- depend on clockwise. Investigations done will be CBCBTCTESRHIVHBSAGHCVCHEST X RAYif necessary), ProctoscopyColonoscopy & Sigmoidoscopyif necessary).
will be done on of 15 days. Follow up will be done 30 days after completion of trial. |